SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Nurix Therapeutics Insider Sold $431,904 in Shares, SEC Filing Shows

A filing identifies Chief Legal Officer Christine Ring as the seller on November 2, 2026.

NRIX

Related stories